ChiCTR2000033012
尚未开始
/
/
/
2020-05-18
/
/
Mayer-Rokitansky-Küster-Hauser (MRKH)
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
In this study, we aim to evaluate the management of women who suffered from MRKH syndrome and evaluate the outcomes of vaginal dilation therapy or surgical therapy and the associated complications. Besides, it is also valuable to study the sexual function of women to guide the future treatment plan for other MRKH women.
单臂
其它
N/A
/
Departmental funding
/
300
/
2020-05-20
2030-04-30
/
1) All women who suffered from MRKH and requested for vaginoplasty; 2) Age >=18 years old.；
登录查看Women who refuse to join the study.；
登录查看Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong
/
药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
